The transgene was designed with the murine albumin (Alb) promoter driving expression of human coagulation factor VIII (F8) cDNA. This transgene contains an Arginine to Cysteine missense mutation at amino acid 612 (originally stated as 593), which is prevalent in patients with Hemophilia A. (J:178969)